SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-329209
Filing Date
2020-12-30
Accepted
2020-12-30 08:11:01
Documents
13
Period of Report
2020-12-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d56159d8k.htm   iXBRL 8-K 25400
2 EX-99.1 d56159dex991.htm EX-99.1 60165
  Complete submission text file 0001193125-20-329209.txt   220526

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20201229.xsd EX-101.SCH 3082
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20201229_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20201229_pre.xml EX-101.PRE 11416
6 EXTRACTED XBRL INSTANCE DOCUMENT d56159d8k_htm.xml XML 3409
Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 201424178
SIC: 2834 Pharmaceutical Preparations